Status:
ACTIVE_NOT_RECRUITING
Impact of Incomplete Endometrial Ablation
Lead Sponsor:
Maxima Medical Center
Conditions:
Heavy Menstrual Bleeding
Eligibility:
FEMALE
Brief Summary
The aim of the proposed protocol is to study the impact of incomplete endometrial ablation on the PBAC score, reintervention, satisfaction, controlled bleeding and dysmenorrhea at 24 months after Nova...
Detailed Description
The primary outcome is blood loss at 24 months after treatment, measured with the PBAC-score according to Higham. To calculate this score women were asked, in the MIRA and MIRA2 study, to record their...
Eligibility Criteria
Inclusion
- Endometrial ablation between 2012 and 2023 in Máxima Medical Centre
- Women had to suffer from heavy menstrual bleeding
Exclusion
- \- No saved hysteroscopy images or bad quality hysteroscopy images
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT06122363
Start Date
March 1 2023
End Date
December 30 2025
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Máxima MC
Veldhoven, North Brabant, Netherlands, 5500MB